XCH
XCHG Limited
Research: Finviz ↗·Perplexity ↗
No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.
News Summary
NegativeXCHG faced a challenging H1 2026 with revenues declining 18% YoY to $10.3M, gross margins compressing 1,250bps to 38.8%, and operating losses nearly doubling to $11.2M, attributed to customer procurement delays and project schedule shifts. While the company secured a $4.4M capital raise, resolved a Nasdaq compliance issue, and achieved notable wins including the XCharge C7 rollout with EnBW in Germany and U.S. Midwest expansion, the deteriorating financial performance and management reshuffle (President stepping down) signal operational headwinds that offset near-term product momentum.
Red flags
- •Revenue declined 18% YoY ($10.3M vs $12.5M)
- •Gross margin compression of 1,250 basis points (51.3% to 38.8%)
- •Operating loss nearly doubled YoY ($11.2M vs $7.4M)
- •Nasdaq minimum bid price non-compliance notice (though subsequently resolved)
- •President/leadership reshuffle with Aatish Patel stepping down from President role
- •Vague guidance on order timing issues with no clear path to recovery
Fund 13D/13G Filings (1)
Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).
| Fund | Form | ∆ Shares | % of Class | Since Filing | Filed | Src |
|---|---|---|---|---|---|---|
| Citadel Advisors | SC 13G | NEW | 9.7% | -54.6% vs SPY -54.1% abs | 2026-08-14 | ↗ |